摘要Gastric cancer (GC) remains one of the most common lethal diseases. Every year, about 1 million people fall ill and almost 800 thousand people die worldwide1. Surgical treatment has reached its limit. The current advances in immunology and detection of epidermal growth factor molecules (EGFR) in gastric cancer cells allowed to improve the treatment results;however, the metastatic form of this disease is still incurable.
作者单位Federal State Budgetary Institution"National Medical Research Center for Oncology Named After N.N.Blokhin"of the Ministry of Health of Russia,Moscow,Russia[1]State Research Center"Institute of Bioorganic Chemistry Named After Academicians M.M.Shemyakin and Yu.A.Ovchinnikov"of the Russian Academy of Sciences,Moscow,Russia;National Medical Research Center for Obstetrics,Gynecology and Perinatology Named After Academician V.I.Kulakov of the Ministry of Health of Russian Federation,Moscow,Russia[2]State Research Center"Institute of Bioorganic Chemistry Named After Academicians M.M.Shemyakin and Yu.A.Ovchinnikov"of the Russian Academy of Sciences,Moscow,Russia[3]
换一批
换一批
